Inhibition of SATB2 expression in HCC CSCs also suppressed CSC characteristics by inhibiting the expression of pluripotency maintaining factors (c‐Myc, OCT4, KLF4 and SOX2) and stem cell markers (CD24, CD44 and CD133). The gene discussed is SATB2; the disease is hepatocellular carcinoma.